(Q53142665)

English

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.

scientific article published on 21 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Efstathios Kastritis

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Athanasios Dimopoulos

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Eurydiki Michalis

6

object named as

Eurydiki Michalis

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Maria Gkotzamanidou

5

object named as

Maria Gkotzamanidou

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Evangelos Terpos

1

object named as

Evangelos Terpos

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Dimitrios Christoulas

2

object named as

Dimitrios Christoulas

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Eirini Katodritou

3

object named as

Eirini Katodritou

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Anastasia Pouli

8

object named as

Anastasia Pouli

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Sosana Delimpasi

7

object named as

Sosana Delimpasi

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

9

object named as

John Meletis

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

author name string

Cornelia Bratengeier

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Konstantinos Zervas

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

language of work or name

0 references

publication date

21 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

131

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

1466-1471

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

Pathogenesis and management of myeloma bone disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Sclerostin: current knowledge and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Sclerostin and Dickkopf-1 in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-?B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27342

21 January 2018

Identifiers

10.1002/IJC.27342

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22052418

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53142665&oldid=1744575468"